NASDAQ:SCMP (SCMP) (SCMP) Stock Price, News & Analysis → Healthcare Takes A Big Step Forward With The Help Of AI (From The Bull Report) (Ad) Free SCMP Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$18.00▼$18.0050-Day Range$18.00▼$18.0052-Week Range$9.30▼$18.75Volume303,068 shsAverage Volume2.56 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (SCMP) alerts: Email Address Ad Whats On FinancePutin and other countries have a planDid you catch that bombshell Tucker Carlson interview with Vladimir Putin? It’s not about if you like Tucker or think Putin is the devil or whatever. It's all about the fact that the US dollar might be taking a back seat... and soon. Click to kickstart your journey to survive in the new economy About (SCMP) Stock (NASDAQ:SCMP)Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of pharmaceutical products. Its primary focus areas are gastroenterology, ophthalmology and oncology-related disorders. Its product candidates include VTS-270, Lubiprostone (AMITIZA), Unoprostone is opropyl (RESCULA) and CPP-1X/sulindac combination product. VTS-270 is an investigational drug under clinical study for the treatment of Niemann-Pick Disease Type C-1, an ultra-orphan, progressive and fatal disease. AMITIZA is a ClC-2 chloride channel activator, which has been approved for three indications that cover distinct patient types: chronic idiopathic constipation, irritable bowel syndrome with constipation, and opioid-induced constipation. RESCULA is a Big Potassium channel activator used to lower intraocular pressure. CPP-1X/sulindac combination product is meant for the treatment of familial adenomatous polyposis (FAP).Read More Ad Whats On FinancePutin and other countries have a planDid you catch that bombshell Tucker Carlson interview with Vladimir Putin? It’s not about if you like Tucker or think Putin is the devil or whatever. It's all about the fact that the US dollar might be taking a back seat... and soon. Click to kickstart your journey to survive in the new economy SCMP Stock News HeadlinesMarch 27, 2023 | financialpost.comAlibaba founder Jack Ma returns to China, ending year-long sojourn abroad -SCMPSeptember 28, 2022 | reuters.comByteDance to add four directors to expand board to nine -SCMP - ReutersApril 23, 2024 | TradeSmith (Ad)The A.I. story nobody is telling you (Read ASAP)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...September 20, 2022 | bloomberg.comHong Kong Reaches Consensus on Ending Hotel Quarantine: SCMP - BloombergSeptember 14, 2022 | reuters.comPwC HK, KPMG to host U.S. regulator for China inspections -SCMP - ReutersSeptember 12, 2022 | bloomberg.comLithuania Set to Open Taipei Trade Office Tuesday, SCMP Reports - BloombergSeptember 12, 2022 | bloomberg.comLithuania Opens Taipei Trade Office Monday, SCMP Says - BloombergSeptember 10, 2022 | bloomberg.comFive Hong Kongers Jailed for 19 Months Each for Sedition: SCMP - BloombergApril 23, 2024 | TradeSmith (Ad)The A.I. story nobody is telling you (Read ASAP)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...August 17, 2022 | seekingalpha.comRoyal Caribbean seeks approval to sail in Hong Kong - SCMP (NYSE:RCL) - Seeking AlphaAugust 3, 2022 | reuters.comZelenskiy seeking 'direct talks' with China's Xi to help end Ukraine war- SCMP - ReutersJuly 30, 2022 | bloomberg.comHong Kong Rugby Sevens Set to Return in November, SCMP Says - BloombergJuly 26, 2022 | financialpost.comHong Kong says may have to downgrade annual growth forecast in August - SCMP - Financial PostJuly 22, 2022 | news.yahoo.comChinese President Xi Jinping wishes Joe Biden a speedy recovery from Covid-19 - Yahoo NewsJuly 19, 2022 | bloomberg.comXi's Beijing Invite Unanswered by Top Europe Leaders, SCMP Says - BloombergJuly 16, 2022 | finance.yahoo.comChinese military upgrades near disputed Himalayan border viewed as provocative in India - Yahoo FinanceJuly 12, 2022 | bloomberg.comH.K. May Loosen Quarantine by November, Health Chief Tells SCMP - BloombergJuly 10, 2022 | finance.yahoo.comChina presents US with further demands to improve relations at meeting between Foreign Minister Wang Yi and Secretary of State Antony Blinken - Yahoo FinanceJuly 10, 2022 | bloomberg.comHK Mulls Health Code Similar to China to Fight Covid, SCMP Says - BloombergJuly 6, 2022 | finance.yahoo.comChina ready for 'golden era' with the Philippines under Marcos Jnr - Yahoo FinanceJune 26, 2022 | finance.yahoo.comUnder Xi Jinping China-Russia ties are defined by global interests and unity in opposition, report finds - Yahoo FinanceJune 21, 2022 | reuters.comDidi makes privacy fixes to ousted apps in run-up to restoring them - SCMP - ReutersJune 16, 2022 | bloomberg.comHong Kong Cuts Isolation Period for Handover Events, SCMP Says - BloombergJune 15, 2022 | npr.orgWas Hong Kong a colony? Not according to new textbooks, a newspaper says - NPRJune 12, 2022 | finance.yahoo.comJapan calls for 'self-restraint' from China after joint fly-past with Russian fighter jets - Yahoo FinanceJune 9, 2022 | finance.yahoo.comBeijing hits out at Washington over proposed US$120 million arms deal to Taiwan - Yahoo FinanceJune 9, 2022 | news.yahoo.comHong Kong to Isolate 1,000 People Before Any Xi Visit, SCMP Says - Yahoo NewsSee More Headlines Receive SCMP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (SCMP) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/01/2017Today4/23/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryPharmaceuticals Current SymbolNASDAQ:SCMP CUSIP86490910 CIK1365216 Webwww.sucampo.com Phone+1-301-9613400FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesPeter S. Greenleaf (Age 47)Chairman of the Board, Chief Executive Officer Peter P. Pfreundschuh CPA (Age 48)Chief Financial Officer Max Donley (Age 48)Executive Vice President of Global Human Resources, Information Technology and Strategy Matthias Alder (Age 52)Executive Vice President Peter A. Kiener Ph.D. (Age 64)Chief Scientific Officer Alex Driggs (Age 41)General Counsel, Corporate Secretary Peter Lichtlen M.D. (Age 47)Ph.D., Chief Medical Officer John H. Johnson (Age 58)Lead Independent Director Paul R. Edick (Age 62)Director Daniel P. Getman Ph.D. (Age 59)Director More Executives SCMP Stock Analysis - Frequently Asked Questions How were (SCMP)'s earnings last quarter? (SCMP) (NASDAQ:SCMP) issued its quarterly earnings results on Wednesday, November, 1st. The biopharmaceutical company reported $0.27 earnings per share for the quarter, topping the consensus estimate of $0.25 by $0.02. The biopharmaceutical company earned $61.27 million during the quarter, compared to analyst estimates of $58.05 million. (SCMP)'s revenue was up 5.9% compared to the same quarter last year. During the same period in the prior year, the business posted $0.30 EPS. What other stocks do shareholders of (SCMP) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (SCMP) investors own include XOMA (XOMA), SentinelOne (S), Alnylam Pharmaceuticals (ALNY), Teekay Tankers (TNK), Xenon Pharmaceuticals (XENE), Gilead Sciences (GILD), OPKO Health (OPK), Cisco Systems (CSCO), Infinera (INFN) and Micron Technology (MU). This page (NASDAQ:SCMP) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishingtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (SCMP) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
